Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 563 entries
View as:

Pre-operative Hypofractionated Proton Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05917301 Org: User:
Start: 04/18/24 End: 12/31/32 Due: 12/31/33

Automated Method for Breast Cancer Detection

Phase: N/A Priority: Normal
NCT ID: NCT03863522 Org: User:
Start: 03/07/19 End: 12/15/20 Due: 12/15/21

Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002600 Org: User:
Start: 10/21/94 End: 07/25/01 Due: 07/25/02

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00006025 Org: User:
Start: 01/05/01 End: 12/01/07 Due: 12/01/08

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00499733 Org: User:
Start: 06/30/07 End: 01/09/13 Due: 01/09/14

INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04116073 Org: User:
Start: 04/09/20 End: 12/03/24 Due: 12/03/25

A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02048384 Org: User:
Start: 06/10/14 End: 09/30/19 Due: 09/30/20

Vibrent Smartphone Mobile Application

Phase: N/A Priority: Normal
NCT ID: NCT02421536 Org: User:
Start: 01/14/16 End: 12/31/22 Due: 12/31/23

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03246074 Org: User:
Start: 04/03/18 End: 04/03/23 Due: 04/03/24

Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00769600 Org: User:
Start: 11/30/08 End: 02/28/13 Due: 02/28/14

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00293280 Org: User:
Start: 07/31/05 End: - Due: -

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00369681 Org: User:
Start: 05/31/06 End: 10/31/14 Due: 10/31/15

Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT00670917 Org: User:
Start: 05/07/08 End: 01/19/10 Due: 01/19/11

HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03216499 Org: User:
Start: 09/14/17 End: 06/05/20 Due: 06/05/21

Red Cell Transfusion Goals in Patients With Acute Leukemias

Phase: N/A Priority: Normal
NCT ID: NCT02086773 Org: User:
Start: 04/30/14 End: 09/30/15 Due: 09/30/16

High-Dose Cyclophosphamide for Steroid Refractory GVHD

Phase: N/A Priority: Normal
NCT ID: NCT00492921 Org: User:
Start: 05/31/07 End: 01/31/13 Due: 01/31/14

Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection

Phase: N/A Priority: Normal
NCT ID: NCT06508138 Org: User:
Start: 10/18/23 End: 10/18/27 Due: 10/18/28

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01493154 Org: User:
Start: 04/30/12 End: 10/31/15 Due: 10/31/16

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06315257 Org: User:
Start: 06/30/25 End: 03/31/27 Due: 03/31/28

Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00006452 Org: User:
Start: 04/10/02 End: 03/16/04 Due: 03/16/05

A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03707444 Org: User:
Start: 10/01/18 End: 11/26/19 Due: 11/26/20

Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT02080195 Org: User:
Start: 09/13/16 End: 03/29/17 Due: 03/29/18

Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT01595321 Org: User:
Start: 10/29/12 End: 10/18/23 Due: 10/18/24

Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00372450 Org: User:
Start: 12/31/06 End: 04/11/08 Due: 04/11/09

Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02825875 Org: User:
Start: 06/08/16 End: 04/30/20 Due: 04/30/21